Michael Schmidt

Title: Michael Schmidt: Inventor in Gene Therapy and Viral Vector Research

Introduction

Michael Schmidt is an inventor based in Kensington, Maryland. His patent work includes research on adeno-associated viral vectors and their potential applications in gene delivery and cancer treatment. The available information lists 6 patents associated with him.

Latest Patents

One of Schmidt’s recent patents, “Epidermal Growth Factor Receptor (EGFR) and Methods of Use in Adenoviral-Associated Virus Type 6 (AAV6) Transduction,” describes research linking EGFR expression with AAV6 transduction. Comparative gene analysis and pathway visualization identified a positive correlation, and the research found that EGFR is necessary for vector internalization and acts as a co-receptor for AAV6. This finding supported the development of recombinant AAV6 vectors intended to target and kill certain head and neck tumors with high EGFR activity, which had been resistant to existing therapies.

Another patent, “Bovine Adeno-Associated Viral (BAAV) Vector and Uses Thereof,” concerns a bovine adeno-associated virus and vectors and particles derived from it. The invention also describes methods for delivering nucleic acids to cells using BAAV vectors and particles.

Career Highlights

Schmidt’s listed patent portfolio reflects work on viral-vector design and gene delivery. His inventions address both the biological mechanisms that influence AAV6 transduction and the development of BAAV-based tools for delivering nucleic acids to cells.

Collaborations

Schmidt’s listed coworkers include John A. Chiorini and Ioannis Bossis. His patents are assigned to The United States of America, as Represented by the Secretary, Department of Health and Human Services.

Conclusion

Michael Schmidt’s patent work focuses on adeno-associated viral vectors, their interaction with cellular receptors, and their potential use in gene delivery and targeted cancer research.